AU2754599A - Mucosal microparticle conjugate vaccine - Google Patents

Mucosal microparticle conjugate vaccine

Info

Publication number
AU2754599A
AU2754599A AU27545/99A AU2754599A AU2754599A AU 2754599 A AU2754599 A AU 2754599A AU 27545/99 A AU27545/99 A AU 27545/99A AU 2754599 A AU2754599 A AU 2754599A AU 2754599 A AU2754599 A AU 2754599A
Authority
AU
Australia
Prior art keywords
mucosal
conjugate vaccine
microparticle conjugate
microparticle
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27545/99A
Inventor
Lena Degling Wikingsson
Ingvar Sjoholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innoventus Project AB
Original Assignee
Innoventus Project AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innoventus Project AB filed Critical Innoventus Project AB
Publication of AU2754599A publication Critical patent/AU2754599A/en
Assigned to INNOVENTUS, UPPSALA LIFE SCIENCE AB reassignment INNOVENTUS, UPPSALA LIFE SCIENCE AB Alteration of Name(s) of Applicant(s) under S113 Assignors: DEGLING WIKINGSSON, LENA, SJOHOLM, INGVAR
Assigned to INNOVENTUS PROJECT AB reassignment INNOVENTUS PROJECT AB Alteration of Name(s) of Applicant(s) under S113 Assignors: INNOVENTUS, UPPSALA LIFE SCIENCE AB
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087Polysaccharides; Lipopolysaccharides [LPS]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU27545/99A 1998-02-27 1999-02-26 Mucosal microparticle conjugate vaccine Abandoned AU2754599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9800615A SE9800615D0 (en) 1998-02-27 1998-02-27 Mucosal microparticle conjugate vaccine
SE9800615 1998-02-27
PCT/SE1999/000277 WO1999043349A1 (en) 1998-02-27 1999-02-26 Mucosal microparticle conjugate vaccine

Publications (1)

Publication Number Publication Date
AU2754599A true AU2754599A (en) 1999-09-15

Family

ID=20410340

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27545/99A Abandoned AU2754599A (en) 1998-02-27 1999-02-26 Mucosal microparticle conjugate vaccine

Country Status (7)

Country Link
EP (1) EP1059935A1 (en)
JP (1) JP2002504521A (en)
AU (1) AU2754599A (en)
CA (1) CA2322175A1 (en)
NZ (1) NZ507130A (en)
SE (1) SE9800615D0 (en)
WO (1) WO1999043349A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US7132108B1 (en) 2000-02-08 2006-11-07 Agency For Science, Technology And Research Biodegradable and biocompatible polymeric microspheres encapsulating Salmonella enteritidis bacteria
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
AUPR011700A0 (en) 2000-09-14 2000-10-05 Austin Research Institute, The Composition comprising immunogenic virus sized particles (VSP)

Also Published As

Publication number Publication date
CA2322175A1 (en) 1999-09-02
WO1999043349A1 (en) 1999-09-02
EP1059935A1 (en) 2000-12-20
SE9800615D0 (en) 1998-02-27
JP2002504521A (en) 2002-02-12
NZ507130A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
AU6065998A (en) Influenza vaccine
AU9623898A (en) Vaccines
GB9812613D0 (en) Vaccine
AU4204097A (en) Vaccine composition against malaria
AU1285300A (en) Hiv vaccine
AU2544300A (en) Immunogenic compounds
AU5977700A (en) Vaccines
AU1600401A (en) Malaria vaccine
GB0027072D0 (en) Vaccine
AU6158700A (en) Vaccine
AU2754599A (en) Mucosal microparticle conjugate vaccine
AU5811600A (en) Vaccine
AU6075498A (en) Vaccines
AU2913600A (en) Immunogenic compounds
AU4553100A (en) Tumour-associated antigen
AU8877998A (en) Oral vaccine
AU5274099A (en) Hiv vaccine
AU1101701A (en) Vaccine compositions
AU5084300A (en) New vaccine formulations - 1
AU3196000A (en) 3,3'-diketotrehalose
AU4935700A (en) New vaccine formulations-3
GB9820956D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
GB9807805D0 (en) Vaccine
AUPP546098A0 (en) Vaccine strategy

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: INNOVENTUS, UPPSALA LIFE SCIENCE AB

Free format text: THE FORMER OWNER WAS: INGVAR SJOHOLM, LENA DEGLING WIKINGSSON

PC1 Assignment before grant (sect. 113)

Owner name: INNOVENTUS PROJECT AB

Free format text: THE FORMER OWNER WAS: INNOVENTUS, UPPSALA LIFE SCIENCE AB

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted